Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
MK-6194 for Vitiligo
Recruiting0 awardsPhase 2
Hot Springs, Arkansas
This trial studies the effectiveness and safety of a new treatment for vitiligo, a skin disorder causing discoloration.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.